Commonwealth Retirement Investments LLC Makes New $521,000 Investment in iShares U.S. Pharmaceuticals ETF $IHE

Commonwealth Retirement Investments LLC purchased a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,146 shares of the company’s stock, valued at approximately $521,000. Commonwealth Retirement Investments LLC owned 0.05% of iShares U.S. Pharmaceuticals ETF at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Stratos Wealth Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $555,000. Accurate Wealth Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $6,372,000. D.A. Davidson & CO. acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $1,709,000. Childress Capital Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $1,018,000. Finally, Prevail Innovative Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $4,529,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA IHE opened at $92.59 on Tuesday. The stock has a market capitalization of $999.97 million, a P/E ratio of 17.75 and a beta of 0.50. The company has a 50-day moving average price of $88.39 and a 200-day moving average price of $87.21. iShares U.S. Pharmaceuticals ETF has a 1 year low of $64.46 and a 1 year high of $94.23.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.